Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03060031 · ClinicalTrials.gov registry record · Phase 1
Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain
A Phase 1 study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- Phase 1
- Development phase
- 51
- Enrollment target
NCT03060031 is a Phase 1 study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 51 participants.
The verdict
NCT03060031, a Phase 1 study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 51 participants
- Enrollment target
Study Summary
This experiment will explore the joint effects of social information, social support, associative learning, and oxytocin on the development of placebo analgesia. The investigators predict that socially transmitted placebo effects will be enhanced by nasal administration of oxytocin, whereas associative learning effects on pain will not be altered by this pharmacological manipulation
Interventions
- DRUG Placebo
- DRUG Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2017-06-21 |
| Est. Completion | 2019-04-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03060031
The ClinicalTrials.gov registry entry for NCT03060031 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03060031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03060031 about?
NCT03060031 is a clinical study titled "Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain". This experiment will explore the joint effects of social information, social support, associative learning, and oxytocin on the development of placebo analgesia. The investigators predict that socially transmitted placebo effects will be enhanced by nasal administration of oxytocin, whereas associat...
What is the current status of trial NCT03060031?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 51 participants. The study started on 2017-06-21. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT03060031?
The interventions under investigation include: Placebo (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT03060031?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.